Pediatrix Medical Group I...

NYSE: MD · Real-Time Price · USD
16.02
0.48 (3.09%)
At close: Aug 15, 2025, 3:05 PM

Pediatrix Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
39.26M 20.74M 30.48M 19.44M -153.03M 4.04M -124.29M 21.39M 28.28M 14.21M 24M 28.81M 30.7M -20.94M 40.28M 31.85M 30.53M 5.35M
Depreciation & Amortization
5.31M 5.33M 6.87M 6.96M 8.79M 10.31M 9.06M 9.21M 8.95M 8.95M 9.14M 8.96M 8.78M 8.77M 7.86M 8.15M 8.11M 8.03M
Stock-Based Compensation
3.91M 3.64M 2.74M 4.11M 1.95M 3.07M 3.02M 3.16M 3.13M 3.01M 3.24M 4.12M 4.34M 4.43M 4.02M 5.5M 5.74M 3.72M
Other Working Capital
4.55M -7.47M 76.85M 4.72M 17.06M 8.73M 21.4M 11.17M -14.31M 128.78M -9.32M 38.14M 129.54M -121.42M 54.54M 49.64M 48.46M 338.44M
Other Non-Cash Items
-1.48M -1.88M -7.34M 6.01M 142.33M -1.06M 163.22M -1.6M -3.72M -271K -665K -5.34M 118K 49.44M -30.71M -4.85M -23.86M 31.63M
Deferred Income Tax
12.11M 4.4M 13.75M 9.15M -25.71M 686K -7.35M 2.21M 6.37M 2.01M -14.07M -6.81M -4.28M 2.39M -1.05M -13.16M -1.02M -16.02M
Change in Working Capital
78.06M -149.69M 86.51M 55.05M 84.61M -139.66M 25.58M 45.56M 46.05M -128.82M 77.05M 53.59M 42.76M -141.57M 23.84M 33.62M 34.09M -114.9M
Operating Cash Flow
137.17M -117.46M 133.01M 91.84M 106.95M -125.23M 69.25M 79.94M 89.05M -100.92M 98.69M 83.33M 82.41M -97.48M 44.24M 61.1M 53.59M -82.19M
Capital Expenditures
-4.51M -3.32M -3.44M -6.29M -6.96M -5.33M -9.04M -9.15M -8.13M -7M -9.06M -6.95M -6.56M -7.14M -3.17M -10.54M -9.48M -9.05M
Cash Acquisitions
n/a n/a n/a n/a n/a -8.17M -5M n/a 2.27M -1.67M n/a n/a -2.5M -25.67M -10.38M -12.34M 23.48M -5.96M
Purchase of Investments
-13.77M -7.76M -10.14M -14.49M -23.02M -16.9M -5.42M -8.72M -8.21M -9.55M -2.41M -1.96M -11.71M -1.27M -3.62M -23.08M -3.22M -5.14M
Sales Maturities Of Investments
11.08M 7.3M 7.17M 14.08M 17.09M 14.15M 6.34M 3.75M 5.95M 6.87M 1M 1.85M 6.33M 7.71M 1M 4.75M 3.31M 7.43M
Other Investing Acitivies
49K -3.69M 4.48M 2.36M -5.93M -2.74M 691K 116K -2.27M -2.68M -775K 964K 1.09M 99K 584K -18.33M 24.82M 2.35M
Investing Cash Flow
-7.15M -7.46M -1.94M -4.34M -12.89M -16.24M -12.42M -14M -10.4M -11.35M -11.24M -6.09M -13.35M -26.27M -15.58M -41.21M 14.09M -10.36M
Debt Repayment
-5.19M -5.03M -3.97M -3.78M -83.83M 76.19M -3.64M -44.83M -76.83M 106.17M -94.86M -62.54M 860K -256.55M -1.01M -690K -434K -760.52M
Common Stock Repurchased
-209K -1.57M -643K -162K -11K -887K n/a -133K -11K -775K -1.47M -21.48M -64.4M -1.17M n/a -2.47M -251K -1.99M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-34K -101K -1.08M -27K 33K 46K -2.15M -6.83M -3.69M 2.08M 8.87M 1.35M 1.39M 86K 596K n/a n/a -189K
Financial Cash Flow
-4.26M -6.04M -4.96M -3.07M -82.66M 76.2M -4.75M -50.6M -78.93M 108.57M -86.29M -82.66M -62.15M -256.46M 825K -131K 851K -761.66M
Net Cash Flow
125.75M -130.96M 126.11M 84.43M 11.4M -65.26M 52.08M 15.33M -275K -3.7M 1.16M -5.42M 6.91M -380.21M 29.48M 19.76M 68.53M -854.21M
Free Cash Flow
132.65M -120.78M 129.57M 94.43M 99.99M -130.56M 60.21M 70.78M 80.92M -107.92M 89.63M 76.38M 75.85M -104.63M 41.07M 50.56M 44.1M -91.24M